LivsMed Decides to Acquire Tangible Assets Worth 31.2 Billion KRW for Next-Gen Surgical Robot Global Manufacturing Base
LivsMed plans to acquire land and buildings worth approximately 31.2 billion KRW to establish an Advanced Manufacturing Facility for next-generation surgical robot global mass production.
The counterparty is Hana Asset Trust, a highly credible institution, and an external evaluation by Induk Accounting Corp. deemed the acquisition price appropriate.
Funding will come from internal cash and bank loans, and the previous lien issue has been resolved, ensuring the schedule proceeds smoothly.
This tangible asset acquisition does not involve new share issuance, so no dilution of existing shareholder value occurs.
[AI Summary]LivsMed invests 31.2 billion KRW to secure production facilities for next-gen surgical robots, strengthening future growth drivers. Funding via debt and equity avoids share dilution. Low investment risk due to credible counterparty and fair valuation, with expected mid-to-long-term profitability improvement from expanded production capacity.
KOSDAQ Filing Information
[Correction of Description] Report on Material Fact (Decision on Acquisition of Tangible Assets)